Post screen-detected breast cancer within the Screening Mammography Program of British Columbia

被引:0
|
作者
T. Gregory Hislop
Ann J. Worth
Lisa Kan
Eunice Rousseau
机构
[1] BC Cancer Agency,Division of Epidemiology and Cancer Prevention
[2] Screening Mammography Program of British Columbia,undefined
来源
关键词
breast cancer; mammography; post screen-detected cancer;
D O I
暂无
中图分类号
学科分类号
摘要
The histological characteristics and extent of mammographic density were compared between 170 post screen-detected (PSD) breast cancers and 466 screen-detected (SD) breast cancers in women attending the Screening Mammography Program of British Columbia. In addition, methods of detection and clinical presentation for the PSD cancers were examined. Invasive ductal, comedo, and medullary carcinoma were significantly more common in PSD cancer in women under age 50 years, and invasive ductal carcinoma in women over age 50 years. Mammographic density was more common in PSD cancers for all age groups under 70 years. The majority of PSD cancers were node negative with no evidence of metastases; however, they tended to be of more advanced stage than SD cancer. Most PSD cancers regardless of age were initially found by the woman herself, presenting as a palpable mass, and the likelihood of being detected within 12 months of the last screening mammogram was higher at younger ages.
引用
收藏
页码:235 / 242
页数:7
相关论文
共 50 条
  • [1] Post screen-detected breast cancer within the Screening Mammography Program of British Columbia
    Hislop, TG
    Worth, AJ
    Kan, L
    Rousseau, E
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1997, 42 (03) : 235 - 242
  • [2] Molecular profiles of screen-detected breast cancers from a Turkish breast cancer screening program
    Cabioglu, Neslihan
    Gurdal, Sibel Ozkan
    Kayhan, Arda
    Ozaydin, Nilufer
    Aribal, Erkin
    Ozmen, Vahit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] CONTRAST ENHANCED MAMMOGRAPHY IN FURTHER ASSESSMENT OF SCREEN-DETECTED BREAST CANCER
    MacCallum, Caroline
    Elder, Kenneth
    Nickson, Carolyn
    Ruecker, Kelly
    Park, Allan
    Rose, Allison
    Mann, Gregory Bruce
    [J]. BREAST, 2023, 68 : 236 - 236
  • [4] Contrast enhanced mammography in further assessment of screen-detected breast cancer
    Maccallum, C.
    Mann, G. B.
    Rose, A.
    Nickson, C.
    Ruecker, K.
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 175 : S33 - S34
  • [5] Recall and Outcome of Screen-detected Microcalcifications during 2 Decades of Mammography Screening in the Netherlands National Breast Screening Program
    Luiten, Jacky D.
    Voogd, Adri C.
    Luiten, Ernest J. T.
    Broeders, Mireille J. M.
    Roes, Kit C. B.
    Tjan-Heijnen, Vivianne C. G.
    Duijm, Lucien E. M.
    [J]. RADIOLOGY, 2020, 294 (03) : 528 - 537
  • [6] Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer
    MacCallum, Caroline
    Elder, Kenneth
    Nickson, Carolyn
    Ruecker, Kelly
    Park, Allan
    Mann, G. Bruce
    Rose, Allison K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024,
  • [7] Mammographic density and histopathologic characteristics of screen-detected tumors in the Norwegian Breast Cancer Screening Program
    Moshina, Nataliia
    Ursin, Giske
    Hoff, Solveig Roth
    Akslen, Lars A.
    Roman, Marta
    Sebuodegard, Sofie
    Hofvind, Solveig
    [J]. ACTA RADIOLOGICA OPEN, 2015, 4 (09)
  • [8] Overdiagnosis of screen-detected breast cancer
    Milch, Vivienne
    Aranda, Sanchia
    Canfell, Karen
    Varlow, Megan
    Roder, David M.
    Currow, David
    Anderiesz, Cleola
    Keefe, Dorothy
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2021, 214 (10) : 455 - +
  • [9] The Management of Screen-detected Breast Cancer
    Ahmed, Muneer
    Douek, Michael
    [J]. ANTICANCER RESEARCH, 2014, 34 (03) : 1141 - 1146
  • [10] Stages of screen-detected breast cancer
    K Koufopoulos
    I Garas
    Ch Pateras
    E Ampatzoglou
    P Kakavoulis
    A Michas
    S Gravas
    V Sarrou
    D Tsitsimelis
    M Tsompanlioti
    N Papageorgiou
    K Kapridaki
    F De Waard
    [J]. Breast Cancer Research, 2 (Suppl 2)